BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06661720-completion@plaintrial.com
DTSTAMP:20261027T143243Z
DTSTART;VALUE=DATE:203711
SUMMARY:Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunothe
 rapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Can
 cer — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06661720
URL:https://plaintrial.com/trial/NCT06661720
END:VEVENT
END:VCALENDAR